Gene · 5892
Papers2,681
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,681
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Communication With Clinicians and Relatives About Cascade Genetic Testing in Cancer Patients With Germline Pathogenic Variants. | JCO Precis Oncol | 2026 | 42234943 | PubTator, text mining | PubMed |
| Particulate Hexavalent Chromium Inhibits RAD51 Paralogs Necessary for RAD51 Filament Formation and Stabilization During Homologous Recombination Repair. | Occup Health (Auckl) | 2026 | 42169974 | PubTator, text mining | PubMed |
| HRR gene promoter methylation-guided nomogram predicts PARP inhibitor efficacy and progression-free survival in high-grade serous ovarian cancer. | Clin Epigenetics | 2026 | 42157333 | PubTator, text mining | PubMed |
| FIMBRIMENOP-2402 trial: evaluating fimbriectomy with delayed oophorectomy in patients with high-risk tubo-ovarian cancer. | Int J Gynecol Cancer | 2026 | 42140840 | PubTator, text mining | PubMed |
| Germline Pathogenic Variants in Breast Cancer-Predisposing Genes Among Early-Onset Female and Male Breast Cancer in Ethiopia. | JCO Glob Oncol | 2026 | 42139642 | PubTator, text mining | PubMed |
| Cancer mutations in RAD51 and its paralogues. | PLoS One | 2026 | 42133623 | PubTator, text mining | PubMed |
| Efficacy of olaparib in advanced cancers with somatic or germline mutations in BAP1, BARD1, BRIP1 and PALB2. | ESMO Open | 2026 | 42105598 | PubTator, text mining | PubMed |
| The contribution of rare germline variants to the immune landscape of breast cancer. | Genome Med | 2026 | 42104457 | PubTator, text mining | PubMed |
| The DNA helicase HELQ promotes replication fork reversal in coordination with BRCA2- and FANCD2-mediated repair pathways. | Nucleic Acids Res | 2026 | 42055550 | PubTator, text mining | PubMed |
| Structural insight into how RAD51 paralog exchange regulates RAD51 filament formation. | Nat Struct Mol Biol | 2026 | 42020761 | PubTator, text mining | PubMed |
| Short-Term Lymphocyte Culture Improves the Diagnostic Yield of Targeted RNA NGS in Cancer Predisposition Testing. | Folia Biol (Praha) | 2026 | 41979997 | PubTator, text mining | PubMed |
| Differential sensitivity of MCPH1- and BRCA2-deficient cancer cells to PARP-1 inhibition. | PLoS One | 2026 | 41931484 | PubTator, text mining | PubMed |
| Germline Mutations Related to Complete Remission After Neoadjuvant Chemotherapy in Patients With Triple-negative Breast Cancer. | J Breast Cancer | 2026 | 41918184 | PubTator, text mining | PubMed |
| Personalized Decision-Making in Risk-Reducing Surgery of the Ovaries. | JAMA Netw Open | 2026 | 41915393 | PubTator, text mining | PubMed |
| Re-evaluating hereditary breast and ovarian cancer risk: clinical impact of updated multigene panel sequencing and genetic counseling. | Fam Cancer | 2026 | 41894033 | PubTator, text mining | PubMed |
| 3D pentaculture model unveils malignant cell-driven macrophage polarization in high-grade serous ovarian cancer. | Nat Commun | 2026 | 41881987 | PubTator, text mining | PubMed |
| Genomic characterization of antimicrobial resistance and virulence determinants in Salmonella Infantis isolated from human, food, and animal sources. | Appl Environ Microbiol | 2026 | 41870134 | PubTator, text mining | PubMed |
| Unraveling small non-coding RNAs with a significant post-transcriptional impact on breast cancer cell signaling, using a combinational sequencing approach. | Funct Integr Genomics | 2026 | 41866548 | PubTator, text mining | PubMed |
| Spatial tumor evolution panorama of ovarian cancer. | Cell Rep Med | 2026 | 41850247 | PubTator, text mining | PubMed |
| Oncological Genetic Counseling in Hereditary Breast and Ovarian Cancers and Lynch Syndrome High-Risk Subjects: Evaluation of Efficacy and Outcomes Using the Genomics Outcome Scale. | Hum Mutat | 2026 | 41809563 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5892/papers?page=2